Clinical Trials Browser

Phase NA × Sunitinib × Other solid neoplasm × Clear all

NCT02450123 2022-06-15

Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors

Phase NA Completed

Other solid neoplasm

Refractory Solid Tumors

NCT00798889 2013-01-21

Rollover Protocol for Prior SU011248 Protocols

Phase NA Completed

314 enrolled 6 charts

Other solid neoplasm

Solid Tumors